LIPOCINE CHAIRMAN AWARDED PRESTIGIOUS "ORDER OF THE RISING SUN" BY THE JAPANESE GOVERNMENT

LIPOCINE INC. STRENGTHENS ITS ORAL TESTOSTERONE IP PORTFOLIO

LIPOCINE AWARDED $978,000 IN GRANTS FOR QUALIFYING THERAPEUTIC DISCOVERY PROJECTS

LIPOCINE INC. ANNOUNCES MILESTONE PAYMENT FROM ABBOTT

SOLVAY PHARMACEUTICALS, INC. LICENSES EXCLUSIVE DEVELOPMENT AND COMMERCIAL RIGHTS TO ORAL TESTOSTERONE FORMULATION FROM LIPOCINE. INC.

LIPOCINE ESTABLISHES CLINICAL FEASIBILITY OF ONCE-A-DAY ZIPRASIDONE

ADAMS RESPIRATORY THERAPEUTICS AND LIPOCINE ENTER INTO LICENSE AND COLLABORATION AGREEMENT